Topics


Diffuse midline glioma | Treatment | Clinical trials | Omburtamab






Home > Publications > Topics > Diffuse midline glioma > Treatment > Clinical trials > Omburtamab






Souweidane MM, Bander ED, Zanzonico P, Reiner AS, Manino N, Haque S, Carrasquillo JA, Lyashchenko SK, Thakur SB, Lewis JS, Donzelli M, Cheung NV, Larson SM, Kramer K, Pandit-Taskar N, Dunkel IJ.
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG).
Neuro Oncol. 2025 Feb 19:noaf039. doi: 10.1093/neuonc/noaf039. PMID: 39969230. Interventional study˰ ˍ